We report a case of a 72-year-old male patient with coronary artery disease who was referred to our institution for repeated ablation of sustained ventricular tachycardia (VT). In 1992 and 2002, the patient suffered an anterior myocardial infarction which was revascularized with coronary artery bypass grafts in 2002. As his left systolic ventricular function was severely impaired (ejection fraction of 24%), he received an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death in 2003. He also suffers from diabetes mellitus, obstructive sleep apnea, peripheral vascular disease, and chronic obstructive pulmonary disease. Furthermore, he was on optimal pharmacologic therapy for heart failure for many years, including beta-blocker (bisoprolol 10 mg), 
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In 2015, the patient was hospitalized due to an electrical storm with recurrent sustained VTs requiring multiple shocks from his ICD. He underwent radiofrequency catheter ablation. In addition to his medication with a beta-blocker, an antiarrhythmic drug regimen with amiodarone was initiated to suppress further ventricular tachyarrhythmias [1] .
Three months later he was hospitalized again because of acute chest pain. A 12-lead electrocardiogram (ECG) showed a sustained slow VT with a rate of 134 bpm, corresponding to a tachycardia cycle length of 448 ms (Fig. 1A) . Due to the therapy with amiodarone, the VT was slow and below the programmed cutoff rate of 176 bpm for VT detection of the ICD [2] . Therefore, no antitachycardia pacing or defibrillation of the ICD occurred. The ECG of the VT documented a negative QRS in the inferior leads and in lead V4-V6, as well as a positive QRS in lead V1-V3 suggesting an inferolateral midventricular origin of the VT [3] . The VT could successfully be terminated in the emergency room with manual overdrive-pacing via 
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www.cardiologyjournal.org the ICD. A coronary angiography showed patent bypass grafts and excluded progression of coronary artery disease. After reprogramming the ICD to a lower VT detection zone, as well as increasing the number and length of anti-tachycardia pacing (ATP), the slow VTs were adequately detected and successfully terminated after several ATP attempts. Since the patient suffered from recurrent symptomatic VTs despite ICD reprogramming, he was referred for catheter ablation. At the beginning of the electrophysiological study, the clinical VT could easily be induced showing the clinical QRS morphology. In general anesthesia, a bipolar voltage map (Fig. 1C) of the left ventricle with a novel multi-polar high-density mapping PENTARAY ® catheter (Biosense Webster, Diamond Bar, CA) was acquired in sinus rhythm (Fig. 1B ) via transseptal and retrograde catheter access sequentially. This high-density mapping catheter consists of 20 poles (1 mm electrode dimension, 2-6-2 mm spacing size), arranged in 5 soft spines covering a diameter of 3.5 cm. Together with a new software (CONFIDENSE TM module) of the electrophysiology navigation system CARTO 3 (Biosense Webster, Diamond Bar, CA), it is able to automatically collect electrode locations and electrical information (activation and voltage) of the tissue in contact in up to 10 different locations simultaneously. With this novel mapping catheter we were able to collect local voltages of over 2,500 different locations from the left ventricular endocardium within a short period of time. Areas of low voltage < 0.5 mV were considered dense scar and were marked in red in the voltage map. Two different areas of dense scar tissue could be identified -one inferolateral midventricular area (as suggested by the clinical VT) and one at the apex. Surviving myocytes within the dense scar lead to a zone of slow conduction and, combined with areas of anatomic or functional conduction block, give rise to electric re-entry circuits [4] [5] [6] [7] [8] [9] . At the border zones of these areas, fractionated and late potentials were identified by this novel multipolar high-density mapping catheter (Fig. 1C) , while no abnormal signals were seen with the conventional 3.5 mm tip ablation catheter (Fig. 2) . Ablation was applied point-by-point in these distinct areas representing a critical pathway of the ventricular reentrant circuit (brown points in Fig. 1C) . At the end of the procedure the clinical VT could not be induced by programmed stimulation with up to 4 extrastimuli. The patient could be discharged the following day and remained free from ventricular tachyarrhythmias.
